Article Information
History
- September 25, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marc Hilmi, M.D.1,2,*,
- Ines Khati, M.P.H.3,*,
- Anthony Turpin, M.D.2,4,
- Antoine Andremont, M.D., Ph.D5,
- Charles Burdet, M.D.6,
- Nathalie Grall, M.D.7,
- Joana Vidal, M.D.8,9,
- Philippe-Jean Bousquet, M.D.3,
- Benoît Rousseau, M.D.Ph.D.2,8,#,† and
- Christine Le Bihan-Benjamin, M.D.3,#
- 1Department of Medical Oncology, Institut Curie, Versailles Saint-Quentin University, Saint-Cloud, France
- 2GERCOR, Paris, France
- 3Department of Health Data and Assessment, Health Survey, Data-science and Assessment Division, French National Cancer Institute (INCa), Boulogne Billancourt, France
- 4Department of Medical Oncology, Lille University Hospital, Lille, France
- 5INSERM IAME UMR 1137, Paris, France
- 6Department of Epidemiology, Biostatistics and Clinical Research, Bichat Hospital, AP-HP, Paris, France
- 7Microbiology Laboratory, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France
- 8Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, USA
- 9Department of Medical Oncology, Hospital del Mar, IMIM, CIBERONC, Barcelona, Spain
- ↵†Corresponding author:
Benoît Rousseau, MD, PhD Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Email: rousseab{at}mskcc.org, Tel: +1 (646) 431-2420